Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.31 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.31 |
| ▸ | ITGAL | P20701 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3453682 | 0.91 | HPGD (0.34) | HPGDMEN1KMT2A | |
| SCHEMBL11390041 | 0.79 | MEN1 (0.38) | HPGDMEN1KMT2AALDH1A1CYP2C19 | |
| SCHEMBL28354526 | 0.76 | HPGD (0.33) | HPGDSMN1; SMN2 | |
| SCHEMBL15271699 | 0.76 | HPGD (0.35) | HPGDMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL28355079 | 0.74 | CES2 (0.35) | MEN1KMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL9910591 | 0.72 | MEN1 (0.36) | HPGDMEN1KMT2ACYP1A2 | |
| SCHEMBL10774794 | 0.72 | GPR84 (0.33) | HPGDMEN1KMT2AITGB2ICAM1 | |
| SCHEMBL30225695 | 0.72 | GPR84 (0.33) | HPGDMEN1KMT2AITGB2ICAM1 | |
| SCHEMBL14216990 | 0.72 | RECQL (0.36) | HPGDMEN1KMT2AALDH1A1CYP2C19 | |
| SCHEMBL28355150 | 0.71 | CES2 (0.41) | HPGDALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250243325-A1 | PHOSPHORUS-31 MRI AGENTS | UNIVERSITEIT TWENTE (NL) | 2025-07-31 | — | — | US | disclosed |
| EP-4522679-A1 | PHOSPHORUS-31 MRI AGENTS | UNIVERSITEIT TWENTE (NL) | 2025-03-19 | — | — | EP | disclosed |
| CN-119095901-A | Phosphorus-31 MRI reagent | 特文特大学 | 2024-12-06 | — | — | CN | disclosed |
| WO-2023217708-A1 | PHOSPHORUS-31 MRI AGENTS | UNIVERSITEIT TWENTE (NL) | 2023-11-16 | — | — | WO | disclosed |
| EP-2736103-B1 | Oxyphosphorous-containing polymers as binders for battery cathodes | SEEO INC (US) | 2022-08-10 | — | — | EP | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20200185773-A1 | Electrolyte for Lithium Secondary Battery and Lithium Secondary Battery Including the Same | SK ON CO., LTD. (KR) | 2020-06-11 | — | — | US | disclosed |
| EP-3621141-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-03-11 | — | — | EP | disclosed |
| CN-110590848-A | Flame-retardant additive and preparation method and application thereof | 恒大新能源科技集团有限公司 | 2019-12-20 | — | — | CN | disclosed |
| US-20190229372-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-07-25 | — | — | US | disclosed |
| CN-103259044-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | MITSUBISHI CHEM CORP | 2013-08-21 | — | — | CN | disclosed |
| US-20120177988-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120070731-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-03-22 | — | — | US | disclosed |
| EP-1761501-B1 | USE OF N-PHENYLPYRAZOLE DERIVATIVES AS PESTICIDES | MERIAL LTD (US) | 2011-10-19 | — | — | EP | disclosed |
| US-7820709-B2 | N-phenylpyrazole derivatives as pesticides | MERIAL LIMITED (US) | 2010-10-26 | — | — | US | disclosed |
| US-20090325065-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
| EP-2012386-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
| US-20070281987-A1 | N-phenylpyrazole derivatives as pesticides | MERIAL, INC. | 2007-12-06 | — | — | US | disclosed |
| EP-1761501-A1 | USE OF N-PHENYLPYRAZOLE DERIVATIVES AS PESTICIDES | Merial Ltd. (US) | 2007-03-14 | — | — | EP | disclosed |
| WO-2006000314-A1 | N-PHENYLPYRAZOLE DERIVATIVES AS PESTICIDES | MERIAL LTD. (US) | 2006-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070281987-A1 | N-phenylpyrazole derivatives as pesticides | ACHE, CYP3A5, PTMS | HPGD 1626/4885MEN1 3884/4885KMT2A 2022/4885 |
| US-20250243325-A1 | PHOSPHORUS-31 MRI AGENTS | PHOSPHO1, PLCB3, INPP5B | HPGD 3270/4885MEN1 166/4885KMT2A 3408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.